General Information of the Compound
| Compound ID |
CP0044035
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
1-(p-chlorophenyl)-1-(2-pyridyl)-3-N,N-dimethylpropylamine
Show/Hide
|
||||||||||||||||||
| Synonyms |
1-(p-Chlorophenyl)-1-(2-pyridyl)-3-N,N-dimethylpropylamine
1-(p-Chlorophenyl)-1-(2-pyridyl)-3-dimethylaminopropane
2-(p-Chloro-alpha-(2-(dimethylamino)ethyl)benzyl)pyridine
3-(4-chlorophenyl)-N,N-dimethyl-3-(pyridin-2-yl)propan-1-amine
3-(4-chlorophenyl)-N,N-dimethyl-3-pyridin-2-ylpropan-1-amine
3-(p-Chlorophenyl)-3-(2-pyridyl)-N,N-dimethylpropylamine
4-Chloropheniramine
Aller-Chlor
Allergican
Allergisan
Antagonate
CHLORPHENIRAMINE (SEE ALSO: CHLORPHENIRAMINE MALEATE (CAS113-92-8))
Chlo-amine
Chlor-Pro
Chlor-Trimeton (TN)
Chlor-Trimeton Repetabs
Chlor-Tripolon (TN)
Chlor-trimeton
Chloropheniramine
Chlorophenylpyridamin
Chlorophenylpyridamine
Chloropiril
Chloroprophenpyridamine
Chlorphenamine
Chlorphenamine (INN)
Chlorphenamine [INN]
Chlorphenaminum
Chlorphenaminum [INN-Latin]
Chlorpheniramine
Chlorpheniraminum
Chlorprophenpyridamine
Clofeniramina
Clofeniramina (TN)
Clorfenamina
Clorfenamina [INN-Spanish]
Clorfeniramina
Clorfeniramina [Italian]
Cloropiril
Comakin (TN)
Gamma-(4-Chlorophenyl)-N,N-dimethyl-2-pyridinepropanamine
Gamma-(4-Chlorophenyl)-gamma-(2-pyridyl)propyldimethylamine
Gen-Allerate
Haynon
Hayon
Histadur
ISOCLOR
Kloromin
Novo-Pheniram
Pediacare Allergy Formula
Phenetron
PiriIton
Piriton
Piriton (TN)
Polaronil
Telachlor
Teldrin
[3H]Chlorpheniramine
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C16H19ClN2
|
||||||||||||||||||
| Molecular Weight |
274.795
|
||||||||||||||||||
| Canonical SMILES |
CN(C)CCC(c1ccc(Cl)cc1)c1ccccn1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C16H19ClN2/c1-19(2)12-10-15(16-5-3-4-11-18-16)13-6-8-14(17)9-7-13/h3-9,11,15H,10,12H2,1-2H3
Show/Hide
|
||||||||||||||||||
| InChIKey |
SOYKEARSMXGVTM-UHFFFAOYSA-N
|
||||||||||||||||||
| CAS |
42882-96-2
46970-45-0
132-22-9
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
| DrugBank ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01206, Histamine H1 receptor
Protein ID: PT00897, Potassium voltage-gated channel subfamily H member 2
Protein ID: PT06157, Solute carrier family 22 member 1
Protein ID: PT04368, Solute carrier family 22 member 2
Clinical Information about the Compound